GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AegirBio AB (GREY:AEGBF) » Definitions » EV-to-Revenue

AegirBio AB (AegirBio AB) EV-to-Revenue : 1,725.67 (As of May. 24, 2024)


View and export this data going back to 2023. Start your Free Trial

What is AegirBio AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, AegirBio AB's enterprise value is $5.18 Mil. AegirBio AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil. Therefore, AegirBio AB's EV-to-Revenue for today is 1,725.67.

The historical rank and industry rank for AegirBio AB's EV-to-Revenue or its related term are showing as below:

AEGBF' s EV-to-Revenue Range Over the Past 10 Years
Min: -27.09   Med: 79.34   Max: 71516.25
Current: 1495.57

During the past 4 years, the highest EV-to-Revenue of AegirBio AB was 71516.25. The lowest was -27.09. And the median was 79.34.

AEGBF's EV-to-Revenue is ranked worse than
98.67% of 830 companies
in the Medical Devices & Instruments industry
Industry Median: 3.23 vs AEGBF: 1495.57

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-24), AegirBio AB's stock price is $0.11. AegirBio AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00. Therefore, AegirBio AB's PS Ratio for today is .


AegirBio AB EV-to-Revenue Historical Data

The historical data trend for AegirBio AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AegirBio AB EV-to-Revenue Chart

AegirBio AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EV-to-Revenue
- - 72.02 20.73

AegirBio AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.73 105.41 89.69 428.50 1,604.06

Competitive Comparison of AegirBio AB's EV-to-Revenue

For the Medical Devices subindustry, AegirBio AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AegirBio AB's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AegirBio AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where AegirBio AB's EV-to-Revenue falls into.



AegirBio AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

AegirBio AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=5.177/0.003
=1,725.67

AegirBio AB's current Enterprise Value is $5.18 Mil.
AegirBio AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AegirBio AB  (GREY:AEGBF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

AegirBio AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.11/0
=

AegirBio AB's share price for today is $0.11.
AegirBio AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AegirBio AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of AegirBio AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


AegirBio AB (AegirBio AB) Business Description

Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.

AegirBio AB (AegirBio AB) Headlines

No Headlines